Patients treated with tirzepatide have a significantly increased likelihood of attaining combined key therapeutic targets in the control of type 2 diabetes (T2D) compared with semaglutide, a post hoc ...
Type 2 diabetes (T2D) has historically been regarded as a chronic, irreversible disease. This conventional view has been challenged by growing evidence that lifestyle changes and surgical or medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results